Soluble PD-1 (programmed death-1) molecule with high affinity
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- GUANGDONG XIANGXUE LIFE SCI LTD
- Publication Date
- 2018-05-04
- Estimated Expiration
- Not applicable · inactive patent
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The present invention relates to the field of biotechnology, more specifically to high-affinity soluble programmed death receptor (Programmed Death-1, PD-1) molecules that can recognize programmed death receptor ligand PDL-1 (Programmed Death-1) with high affinity Ligand-1, PDL-1) molecules. The present invention relates to the preparation method and use of this molecule. Background technique
[0002] PD-1 is an immunosuppressive receptor expressed on activated T cells and B cells, and its ligand is PDL-1 or PDL-2. PD-1 belongs to the B7 family and is an Ig superfamily type I transmembrane glycoprotein with a size of 50-55kD; it consists of three parts: the extracellular IgV region, the transmembrane region and the intracellular region. Membrane-proximal cysteine residues, PD-1 exist as monomers (Xuewu Zhang and Almo, Immunity, 2004, 20, 337–347). PD-1 interacts with the ligand PDL-1 and plays an important role in the negative regulation of the im...